-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
EXCLUSIVE: This Cannabis Company Becomes The First To Have THC, CBD Licenses In Uruguay
EXCLUSIVE: This Cannabis Company Becomes The First To Have THC, CBD Licenses In Uruguay
YVY Life Sciences recently became the first company in Uruguay to receive both medical THC and CBD production licenses from the Institute for the Regulation and Control of Cannabis (IRCCA).
Why It Matters
YVY Life Sciences is one of the leading cannabis companies in Uruguay, offering unique experiences and high-quality natural products produced with an innovative and sustainable cultivation model.
The company's main operations are in Uruguay and it is currently launching business activities in Colombia and Argentina. YVY is part of the Terraflos family of companies, which also holds a stake in Blueberries Medical Corp (OTC:BBRRF).
What's Next
According to management, YVY will continue to develop its unique CBD cultivation model with La Armonia, a women's cooperative in Canalones, Uruguay. The partner farm will cultivate medical CBD flowers in greenhouses adhering to good agricultural practices (GACP).
Meanwhile, YVY has commenced its first medical THC cultivation cycle at its new property in Garzon. The cultivation, both in greenhouses and outdoors, will feature unique high-THC and mixed CBD/THC genetics, and be GACP certified as well.
"I'm super proud of our team for achieving this incredible milestone. As the first company in Uruguay to receive both medical CBD and THC cultivation licenses from IRCCA, we're ending 2021 on a big high and promise to continue innovating and pioneering the way forward in 2022," Kevin Nafte, co-founder and head of business development at YVY, told Benzinga.
Both CBD and THC cultivations will be dried and processed in a GMP-compliant facility with the goal of exporting the dried flowers and biomass for final consumption or extraction. Harvests are expected to take place in March and April 2022.
YVY Life Sciences recently became the first company in Uruguay to receive both medical THC and CBD production licenses from the Institute for the Regulation and Control of Cannabis (IRCCA).
依薇生命科学最近成为世界上第一家乌拉圭收到医用THC和CBD的生产许可证都是从大麻调控研究所(IRCCA)获得的。
Why It Matters
为什么这很重要
YVY Life Sciences is one of the leading cannabis companies in Uruguay, offering unique experiences and high-quality natural products produced with an innovative and sustainable cultivation model.
依薇生命科学是乌拉圭领先的大麻公司,提供独特的体验和高质量的天然产品,以创新和可持续的种植模式生产。
The company's main operations are in Uruguay and it is currently launching business activities in Colombia and Argentina. YVY is part of the Terraflos family of companies, which also holds a stake in Blueberries Medical Corp (OTC:BBRRF).
该公司的主要业务在乌拉圭,目前正在哥伦比亚和阿根廷开展业务活动。Yvy是TerraFlos家族公司的一员,该家族还持有蓝莓医疗公司(场外交易:BBRRF)。
What's Next
下一步是什么?
According to management, YVY will continue to develop its unique CBD cultivation model with La Armonia, a women's cooperative in Canalones, Uruguay. The partner farm will cultivate medical CBD flowers in greenhouses adhering to good agricultural practices (GACP).
根据管理层的说法,Yvy将继续发展其独特的CBD培养模式,乌拉圭卡纳洛内斯的妇女合作社La Armonia。合作农场将按照良好农业规范(GACP)在温室内培育药用CBD花卉。
Meanwhile, YVY has commenced its first medical THC cultivation cycle at its new property in Garzon. The cultivation, both in greenhouses and outdoors, will feature unique high-THC and mixed CBD/THC genetics, and be GACP certified as well.
与此同时,Yvy已经在其位于加尔松的新物业开始了第一个医用THC培养周期。温室和室外的栽培,将具有独特的高THC和CBD/THC混合遗传,并通过GACP认证。
"I'm super proud of our team for achieving this incredible milestone. As the first company in Uruguay to receive both medical CBD and THC cultivation licenses from IRCCA, we're ending 2021 on a big high and promise to continue innovating and pioneering the way forward in 2022," Kevin Nafte, co-founder and head of business development at YVY, told Benzinga.
“我为我们的团队取得了这一令人难以置信的里程碑感到超级自豪。作为乌拉圭第一家同时获得IRCCA颁发的医用CBD和THC种植许可证的公司,我们将在2021年以一个很高的速度结束,并承诺在2022年继续创新和开拓前进的道路。”凯文·纳夫特, Yvy的联合创始人兼业务发展主管告诉Benzinga.
Both CBD and THC cultivations will be dried and processed in a GMP-compliant facility with the goal of exporting the dried flowers and biomass for final consumption or extraction. Harvests are expected to take place in March and April 2022.
CBD和THC栽培将在符合GMP的设施中干燥和加工,目标是出口干燥的花卉和生物质用于最终消费或提取。收成预计将在2022年3月和4月进行。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧